Titlebook: Handbook of Cancer and Immunology; Nima Rezaei Living reference work 2025Latest edition Metastasis.Cell Therapy.Cancer Prevention.Cancer

只看該作者 · 發(fā)表于 2025-3-23 18:32:45

https://doi.org/10.1007/978-3-030-80962-1Metastasis; Cell Therapy; Cancer Prevention; Cancer detection; Tumor microenvironment; Immunoediting

只看該作者 · 發(fā)表于 2025-3-24 00:03:41

Nima RezaeiOffers a comprehensive overview of Cancer Immunology and Immunotherapy.Provides a bench to bedside approach to the immunology of cancers.Includes contributions by world renowned experts in the field

只看該作者 · 發(fā)表于 2025-3-24 05:57:59

http://image.papertrans.cn/h/image/420940.jpg

只看該作者 · 發(fā)表于 2025-3-24 09:20:04

Toward an Anthropology of Governmentrs (FcγRs), which are expressed on various immune cells, including NK cells. This activion stimulate cytotoxicity and might be combined with target agents or other checkpoints inbitors. Additionally ADCC activity correlates with better prognosis.

只看該作者 · 發(fā)表于 2025-3-24 13:00:59

只看該作者 · 發(fā)表于 2025-3-24 17:33:32

[18F]FDG PET/CT Imaging in Cancer Treatment with Checkpoint Inhibitors,s revolutionized the landscape in oncology and paved the way for new therapeutic approaches. In this context, the implementation of the immune checkpoint inhibitors (ICI) has made a turning point in the treatment of metastatic solid tumors and relapsed or refractory lymphomas. Thanks to the targetin

只看該作者 · 發(fā)表于 2025-3-24 20:02:08

只看該作者 · 發(fā)表于 2025-3-25 00:04:45

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:19
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved